Royal Bank of Canada’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-201,624
Closed -$13.7M 7608
2022
Q3
$13.7M Sell
201,624
-216,982
-52% -$14.8M ﹤0.01% 1153
2022
Q2
$13.4M Buy
418,606
+66,520
+19% +$2.13M ﹤0.01% 1215
2022
Q1
$12.2M Buy
352,086
+274,497
+354% +$9.51M ﹤0.01% 1379
2021
Q4
$2.27M Buy
77,589
+22,596
+41% +$661K ﹤0.01% 2624
2021
Q3
$1.4M Buy
54,993
+19,076
+53% +$486K ﹤0.01% 2959
2021
Q2
$1.26M Buy
35,917
+1,017
+3% +$35.6K ﹤0.01% 3088
2021
Q1
$1.42M Sell
34,900
-133,631
-79% -$5.45M ﹤0.01% 2892
2020
Q4
$7.3M Buy
168,531
+70,069
+71% +$3.03M ﹤0.01% 1674
2020
Q3
$5.43M Buy
98,462
+30,788
+45% +$1.7M ﹤0.01% 1701
2020
Q2
$4.27M Buy
67,674
+8,088
+14% +$511K ﹤0.01% 1799
2020
Q1
$3.04M Buy
59,586
+15,877
+36% +$811K ﹤0.01% 1872
2019
Q4
$3.47M Buy
43,709
+23,468
+116% +$1.87M ﹤0.01% 2033
2019
Q3
$982K Buy
20,241
+19,134
+1,728% +$928K ﹤0.01% 2849
2019
Q2
$58K Sell
1,107
-981
-47% -$51.4K ﹤0.01% 4531
2019
Q1
$110K Sell
2,088
-383
-15% -$20.2K ﹤0.01% 4126
2018
Q4
$101K Sell
2,471
-89
-3% -$3.64K ﹤0.01% 4093
2018
Q3
$97K Sell
2,560
-157,266
-98% -$5.96M ﹤0.01% 4284
2018
Q2
$7.22M Sell
159,826
-15,287
-9% -$691K ﹤0.01% 1461
2018
Q1
$8.46M Buy
175,113
+115,746
+195% +$5.59M ﹤0.01% 1387
2017
Q4
$2.34M Buy
59,367
+55,226
+1,334% +$2.17M ﹤0.01% 2112
2017
Q3
$129K Buy
4,141
+3,506
+552% +$109K ﹤0.01% 4123
2017
Q2
$17K Buy
635
+198
+45% +$5.3K ﹤0.01% 4862
2017
Q1
$16K Sell
437
-971
-69% -$35.6K ﹤0.01% 5067
2016
Q4
$21K Buy
1,408
+743
+112% +$11.1K ﹤0.01% 4991
2016
Q3
$15K Hold
665
﹤0.01% 4900
2016
Q2
$11K Hold
665
﹤0.01% 5018
2016
Q1
$11K Buy
+665
New +$11K ﹤0.01% 5001
2015
Q4
Sell
-400
Closed -$17K 6067
2015
Q3
$17K Buy
+400
New +$17K ﹤0.01% 5048